Nature Reviews Clinical Oncology
ISSN 1759-4774 · Nature Portfolio · United Kingdom · active 1965–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Nature Reviews Clinical Oncology a predatory journal?
Our screening does not flag Nature Reviews Clinical Oncology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Nature Reviews Clinical Oncology indexed in Scopus or Web of Science?
Per our venue index, Nature Reviews Clinical Oncology appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Nature Reviews Clinical Oncology's impact?
Papers in Nature Reviews Clinical Oncology are cited about 22.5 times each within two years of publication, and Scimago places it in Q1, with an h-index of 280. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Nature Reviews Clinical Oncology open access?
We hold no reliable open-access classification for Nature Reviews Clinical Oncology. Check the journal's own site for its access model and any article processing charge.